• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用大麻与肠道微生物群

Medicinal Cannabis and the Intestinal Microbiome.

作者信息

Vitetta Luis, Nation Tamara, Oldfield Debbie, Thomsen Michael

机构信息

Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

National Institute of Integrative Medicine, Melbourne 3122, Australia.

出版信息

Pharmaceuticals (Basel). 2024 Dec 17;17(12):1702. doi: 10.3390/ph17121702.

DOI:10.3390/ph17121702
PMID:39770543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11678570/
Abstract

Historically, the multiple uses of cannabis as a medicine, food, and for recreational purposes as a psychoactive drug span several centuries. The various components of the plant (i.e., seeds, roots, leaves and flowers) have been utilized to alleviate symptoms of inflammation and pain (e.g., osteoarthritis, rheumatoid arthritis), mood disorders such as anxiety, and intestinal problems such as nausea, vomiting, abdominal pain and diarrhea. It has been established that the intestinal microbiota progresses neurological, endocrine, and immunological network effects through the gut-microbiota-brain axis, serving as a bilateral communication pathway between the central and enteric nervous systems. An expanding body of clinical evidence emphasizes that the endocannabinoid system has a fundamental connection in regulating immune responses. This is exemplified by its pivotal role in intestinal metabolic and immunity equilibrium and intestinal barrier integrity. This neuromodulator system responds to internal and external environmental signals while also serving as a homeostatic effector system, participating in a reciprocal association with the intestinal microbiota. We advance an exogenous cannabinoid-intestinal microbiota-endocannabinoid system axis potentiated by the intestinal microbiome and medicinal cannabinoids supporting the mechanism of action of the endocannabinoid system. An integrative medicine model of patient care is advanced that may provide patients with beneficial health outcomes when prescribed medicinal cannabis.

摘要

从历史上看,大麻作为药物、食物以及作为具有精神活性的娱乐性药物的多种用途跨越了几个世纪。该植物的各个部分(即种子、根、叶和花)已被用于缓解炎症和疼痛症状(如骨关节炎、类风湿性关节炎)、焦虑等情绪障碍以及恶心、呕吐、腹痛和腹泻等肠道问题。已经证实,肠道微生物群通过肠-微生物群-脑轴产生神经、内分泌和免疫网络效应,作为中枢神经系统和肠神经系统之间的双向通信途径。越来越多的临床证据强调,内源性大麻素系统在调节免疫反应方面有着根本联系。这在其对肠道代谢和免疫平衡以及肠道屏障完整性的关键作用中得到了体现。这个神经调节系统对内部和外部环境信号做出反应,同时也作为一个稳态效应系统,与肠道微生物群相互关联。我们提出了一个由肠道微生物群和药用大麻素增强的外源性大麻素-肠道微生物群-内源性大麻素系统轴,支持内源性大麻素系统的作用机制。我们提出了一种综合医疗模式,当给患者开药用大麻时,可能会为患者带来有益的健康结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ff/11678570/bc1c4db86394/pharmaceuticals-17-01702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ff/11678570/96bd431e248c/pharmaceuticals-17-01702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ff/11678570/bc1c4db86394/pharmaceuticals-17-01702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ff/11678570/96bd431e248c/pharmaceuticals-17-01702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ff/11678570/bc1c4db86394/pharmaceuticals-17-01702-g002.jpg

相似文献

1
Medicinal Cannabis and the Intestinal Microbiome.药用大麻与肠道微生物群
Pharmaceuticals (Basel). 2024 Dec 17;17(12):1702. doi: 10.3390/ph17121702.
2
Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.大麻使用的药物史——未来胃肠道疾病药物开发的新可能性。
Int J Mol Sci. 2023 Sep 28;24(19):14677. doi: 10.3390/ijms241914677.
3
Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review.不同临床背景下大麻与大麻素-微生物组的相互作用:一项全面的系统综述。
Biomed Pharmacother. 2025 Jan;182:117764. doi: 10.1016/j.biopha.2024.117764. Epub 2024 Dec 16.
4
Endocannabinoid System: A Multi-Facet Therapeutic Target.内源性大麻素系统:一个多方面的治疗靶点。
Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339.
5
High and Mighty? Cannabinoids and the microbiome in pain.高高在上?大麻素与疼痛中的微生物群
Neurobiol Pain. 2021 Feb 16;9:100061. doi: 10.1016/j.ynpai.2021.100061. eCollection 2021 Jan-Jul.
6
Role of cannabis in inflammatory bowel diseases.大麻在炎症性肠病中的作用。
Ann Gastroenterol. 2020 Mar-Apr;33(2):134-144. doi: 10.20524/aog.2020.0452. Epub 2020 Feb 12.
7
Cannabinoids and the gut: new developments and emerging concepts.大麻素与肠道:新进展与新兴概念。
Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1.
8
Targeting the endocannabinoid system with microbial interventions to improve gut integrity.通过微生物干预靶向作用于内源性大麻素系统以改善肠道完整性。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110169. doi: 10.1016/j.pnpbp.2020.110169. Epub 2020 Nov 11.
9
Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation.肠道微生物群在大麻素介导的炎症抑制中的作用。
Adv Drug Alcohol Res. 2022;2. doi: 10.3389/adar.2022.10550. Epub 2022 Jul 14.
10
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.大麻:一种具有悠久历史的药用植物的全面民族药理学综述。
J Ethnopharmacol. 2018 Dec 5;227:300-315. doi: 10.1016/j.jep.2018.09.004. Epub 2018 Sep 8.

引用本文的文献

1
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy.大麻素对接受免疫检查点抑制剂免疫治疗的患者癌症预后的影响。
Front Immunol. 2025 Mar 5;16:1497829. doi: 10.3389/fimmu.2025.1497829. eCollection 2025.

本文引用的文献

1
How important are fatty acids in human health and can they be used in treating diseases?脂肪酸在人类健康中有多重要?它们能用于治疗疾病吗?
Gut Microbes. 2024 Jan-Dec;16(1):2420765. doi: 10.1080/19490976.2024.2420765. Epub 2024 Oct 27.
2
Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review.了解大麻二酚对精神分裂症患者的潜在益处:一项叙述性综述。
Schizophr Bull Open. 2021 Nov 28;3(1):sgab053. doi: 10.1093/schizbullopen/sgab053. eCollection 2022 Jan.
3
Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure.
大麻的表观遗传效应:与大麻使用和外源性大麻素暴露相关的行为和情绪症状的系统范围综述。
Drug Alcohol Depend. 2024 Oct 1;263:111401. doi: 10.1016/j.drugalcdep.2024.111401. Epub 2024 Jul 27.
4
Therapeutic potential of CBD in Autism Spectrum Disorder.大麻二酚在自闭症谱系障碍中的治疗潜力。
Int Rev Neurobiol. 2024;177:149-203. doi: 10.1016/bs.irn.2024.05.002. Epub 2024 Jun 29.
5
Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome.多囊卵巢综合征患者粪便微生物群的生态失调改变
Microbiol Spectr. 2024 Aug 6;12(8):e0429123. doi: 10.1128/spectrum.04291-23. Epub 2024 Jul 11.
6
Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases.大麻素对胃肠道疾病中肠道动力、屏障通透性的影响及其治疗潜力。
Int J Mol Sci. 2024 Jun 18;25(12):6682. doi: 10.3390/ijms25126682.
7
Cannabidiol improves the cognitive function of SAMP8 AD model mice involving the microbiota-gut-brain axis.大麻二酚通过微生物群-肠-脑轴改善 SAMP8AD 模型小鼠的认知功能。
J Toxicol Environ Health A. 2024 Jun 2;87(11):471-479. doi: 10.1080/15287394.2024.2338914. Epub 2024 Apr 9.
8
Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician.营养、内源性大麻素与大麻的使用:营养临床医生须知。
Nutr Clin Pract. 2024 Aug;39(4):815-823. doi: 10.1002/ncp.11148. Epub 2024 Mar 30.
9
Pesticides: Unintended Impact on the Hidden World of Gut Microbiota.农药:对肠道微生物群隐秘世界的意外影响。
Metabolites. 2024 Mar 7;14(3):155. doi: 10.3390/metabo14030155.
10
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis.整合粪便代谢组学和肠道微生物群以研究大麻二酚治疗特发性肺纤维化的机制。
Front Pharmacol. 2024 Feb 6;15:1358626. doi: 10.3389/fphar.2024.1358626. eCollection 2024.